Cardiovascular effects of super short intense acceleration training in men with high blood pressure
- Conditions
- Hypertension
- Registration Number
- RBR-2vmgq95
- Lead Sponsor
- niversidade Federal de Mato Grosso do Sul - UFMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
Men. Age between thirty and sixty years. Previous medical diagnosis of primary hypertension or use of at least one antihypertensive medication. Stage one arterial hypertension diagnosed at least one year ago. If taking antihypertensive medication that has not changed for at least two months. Have not participated in regular exercise programs in the last three months prior to the study. Agree to sign the informed consent form. Volunteers without arterial hypertension must only meet the criteria for males. Age between thirty and sixty years. Abstained from regular exercise in the last three months. Agree to sign the informed consent form
Significant comorbidities such as heart failure; chronic obstructive pulmonary disease; changes in cognitive impairment or psychiatric illness; previous stroke; neuromuscular disease; asthma; uncontrolled diabetes; peripheral vascular disease; grade three obesity; renal failure; sleep apnea; malnutrition or other diseases that interfere with protocol performance; secondary hypertension; individuals with contraindications to performing a symptom-limited maximal exercise test
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main outcome that is measured at the end of the study to compare two interval training protocols in the acute phase and verify the effects of sSIT training in hypertensive patients is blood pressure. In the acute phase being analyzed during exercise and every 15 min for 60 min and in the chronic phase by monitoring blood pressure during exercise and post exercise using an Ambulatory Blood Pressure Monitor (ABPM) for 24 hours.
- Secondary Outcome Measures
Name Time Method For secondary outcomes, heart rate recovery (HRF), Double Product values and nitric oxide dosage will be verified in both phases of the study.